Concepedia

Author

Emma Morris

University College LondonORCID

Also Known As

E C MORRIS, E C Morris, E MORRIS, E Morris, E. C. Morris, E. MORRIS, E. Morris, E.C. Morris, E. C. Morris, EC Morris

351

Publications

8K

Citations

48

H-Index

137

Concepts

All Affiliations

University College LondonThe Royal Free HospitalRoyal Free London NHS Foundation TrustUniversity College London Hospitals NHS Foundation TrustUniversity College Hospital
EM

About

Emma Morris is an author at University College London specializing in medicine, immunology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

30

1.9K

2

Health Sciences

7

7

320

3

Education

2

2

35

4

Arts

1

1

22

5

Engineering

1

1

37

Emma Morris

×

88

Publications

5.8K

Citations

44

H-Index

YearCitations

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock,

Blood

2004

288

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Karl S. Peggs, Ann Hunter, Rajesh Chopra,

The Lancet

2005

277

Lentiviral gene therapy for X-linked chronic granulomatous disease

Donald B. Kohn, Claire Booth, Elizabeth M. Kang,

Nature Medicine

2020

242

The evolution of cellular deficiency in GATA2 mutation

Rachel Dickinson, Paul Milne, Laura Jardine,

Blood

2013

210

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses

Karl S. Peggs, Kirsty Thomson, Daniel P. Hart,

Blood

2003

204

Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

Waseem Qasim, Maurizia Rossana Brunetto, Adam J. Gehring,

Journal of Hepatology

2014

199

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

Emma Morris, Peppy Rebello, Kirsty Thomson,

Blood

2003

193

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy, Erin Waters, Behzad Rowshanravan,

Nature Immunology

2022

193

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene–transduced human T cells

Shao‐An Xue, Liquan Gao, Daniel P. Hart,

Blood

2005

183

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

Kirsty Thomson, Emma Morris, Adrian Bloor,

Journal of Clinical Oncology

2008

166

Page 1